2024-09-18 - Analysis Report
## DHR Stock Analysis Report

**Company Overview:** DHR, or Danaher Corporation, is a global science and technology company that designs, manufactures, and markets a wide range of products and services.

**1. Performance vs. S&P 500 (VOO):**

DHR has significantly outperformed the S&P 500 (VOO) over the period analyzed, with a cumulative return of 134.85% compared to VOO's 88.56%. The difference in performance is 46.29%, indicating DHR's superior performance.  This puts DHR at the 37.32 percentile in terms of relative outperformance compared to its historical range.

**2. Recent Price Action:**

* **Closing Price:** $272.73
* **5-Day Moving Average:** $273.5
* **20-Day Moving Average:** $269.71
* **60-Day Moving Average:** $262.28

DHR's price is currently slightly below its 5-day moving average but above both its 20-day and 60-day moving averages, indicating short-term consolidation.

**3. Technical Indicators:**

* **RSI:** 56.16  - Suggests the stock is slightly overbought, but not in overbought territory.
* **PPO:** 0.15 - Shows a positive momentum in the price, indicating potential for continued upward movement.
* **Delta_Previous_Relative_Divergence:** 0.28, (+) - Suggests a short-term upward trend.
* **Expected_Return:** 77.75% - Represents a maximum expected return over the next 5 years based on current investment.

**4. Recent Earnings and Outlook:**

| Date         | EPS    | Revenue |
|--------------|--------|---------|
| 2024-07-23 | 1.23  | 5.74 B$ |
| 2024-04-23 | 1.47  | 5.80 B$ |
| 2024-02-21 | 1.46  | 6.41 B$ |
| 2023-10-24 | 1.53  | 5.62 B$ |
| 2024-02-21 | 1.53  | 5.62 B$ |

The most recent earnings report (2024-07-23) showed EPS of 1.23, slightly below the expected EPS. Despite this, DHR continues to show strong revenue growth, indicating positive performance.

**5.  Summary:**

DHR exhibits strong performance against the S&P 500 with significant outperformance in the past, supported by a positive short-term trend. While recent earnings were slightly below expectations, strong revenue growth signals a healthy financial performance.  Technical indicators suggest potential for continued upward momentum, although a slight overbought condition warrants observation.  The high expected return further adds to the positive outlook for DHR. 

**6. Recommendations:**

Based on the current analysis, DHR presents a compelling investment opportunity.  Continued monitoring of its financial performance, particularly regarding earnings and revenue growth, is advised.  Investors seeking exposure to the science and technology sector, particularly with a strong growth potential, may consider DHR for their portfolio. 
